Evidence map›Paper›PMID 34671372›Full record

ArticleFrontiers in plant science2021

The Major Peanut Allergen Ara h 2 Produced in

Öykü Üzülmez, Tanja Kalic, Vanessa Mayr, Nina Lengger, Angelika Tscheppe, Christian Radauer, Christine Hafner, Wolfgang Hemmer, Heimo Breiteneder

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Impact of recombinant expression inFrontiers in immunology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Legumain Functions as a Transient TrkB Sheddase.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Öykü ÜzülmezInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Tanja KalicInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Vanessa MayrInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Nina LenggerInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Angelika TscheppeInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Christian RadauerInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Christine HafnerDepartment of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
Wolfgang HemmerFAZ - Floridsdorf Allergy Center, Vienna, Austria.
Heimo BreitenederInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATKarl Landsteiner University of Health Sciences · ATUniversitätsklinikum St. Pölten · AT

Funding

Austrian Science Fund FWF P 30936
6 · The paper itself

Abstract

Peanut allergy is a potentially life-threatening disease that is mediated by allergen-specific immunoglobulin E (IgE) antibodies. The major peanut allergen Ara h 2, a 2S albumin seed storage protein, is one of the most dangerous and potent plant allergens. Ara h 2 is posttranslationally modified to harbor four disulfide bridges and three hydroxyprolines. These hydroxyproline residues are required for optimal IgE-binding to the DPYSP

Indexed as

Ara h 2hydroxyprolineNicotiana benthamianapeanut allergyPTMtransient expression

Identifiers

PMID34671372
PMCPMC8522509
OpenAlexW3204916924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.